Cardiol Therapeutics (CRDL) Ownership - Who owns Cardiol Therapeutics?
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CRDL showed earnings on May 16, 2025. You can read more about the earnings report here.